Search research articles
Contact Us
Filters
Showing results (11-20 of 74) with videos related to
Page
of 8
Sort By:
The Journal of Clinical Psychiatry
|
May 8, 2025
Clozapine Monitoring in the Post-REMS World: Some Guidance for Clinicians
Jonathan M Meyer, Jose M Rubio
The Journal of Clinical Psychiatry
|
April 28, 2017
Duration and Relevance of Untreated Psychiatric Disorders, 2: Nonpsychotic Psychiatric Disorders and Substance Use Disorders
Jose M Rubio, Christoph U Correll
Schizophrenia Bulletin Open
|
October 24, 2022
Chronic Use of Antipsychotics in Schizophrenia: Are We Asking the Right Question?
Jose M Rubio, Mercedes Perez-Rodriguez
Schizophrenia (Heidelberg, Germany)
|
December 17, 2025
Benefits and risks of antipsychotic discontinuation in people with first and multi-episode psychotic disorders or with schizophrenia: why, when, how and in whom?
Christoph U Correll, Jose M Rubio, John M Kane
Behavioural Brain Research
|
January 8, 2021
Towards a framework to develop neuroimaging biomarkers of relapse in schizophrenia
Jose M Rubio, Anil K Malhotra, John M Kane
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)
|
June 2, 2018
What is the risk-benefit ratio of long-term antipsychotic treatment in people with schizophrenia?
Christoph U Correll, Jose M Rubio, John M Kane
CNS Drugs
|
June 1, 2023
Early Non-Response to Antipsychotic Treatment in Schizophrenia: A Systematic Review and Meta-Analysis of Evidence-Based Management Options
Jose M Rubio, Daniel Guinart, John M Kane, et al.
Schizophrenia Bulletin
|
August 6, 2021
Predictors of Lack of Relapse After Random Discontinuation of Oral and Long-acting Injectable Antipsychotics in Clinically Stabilized Patients with Schizophrenia: A Re-analysis of Individual Participant Data
Georgios Schoretsanitis, John M Kane, Christoph U Correll, et al.
Schizophrenia Research
|
April 3, 2012
Examining the course of hallucinatory experiences in children and adolescents: a systematic review
Jose M Rubio, Julio Sanjuán, Ludwing Flórez-Salamanca, et al.
Psychiatric Services (Washington, D.C.)
|
November 10, 2020
Using Claims Data to Assess Treatment Quality of First-Episode Psychosis
Christopher Reist, Elise Valdes, Yingqian Ren, et al.
Page
of 8
Search research articles
Search
Showing results (11-20 of 74) with videos related to
Sort By:
Page
of 8
The Journal of Clinical Psychiatry
|
May 8, 2025
Clozapine Monitoring in the Post-REMS World: Some Guidance for Clinicians
Jonathan M Meyer, Jose M Rubio
The Journal of Clinical Psychiatry
|
April 28, 2017
Duration and Relevance of Untreated Psychiatric Disorders, 2: Nonpsychotic Psychiatric Disorders and Substance Use Disorders
Jose M Rubio, Christoph U Correll
Schizophrenia Bulletin Open
|
October 24, 2022
Chronic Use of Antipsychotics in Schizophrenia: Are We Asking the Right Question?
Jose M Rubio, Mercedes Perez-Rodriguez
Schizophrenia (Heidelberg, Germany)
|
December 17, 2025
Benefits and risks of antipsychotic discontinuation in people with first and multi-episode psychotic disorders or with schizophrenia: why, when, how and in whom?
Christoph U Correll, Jose M Rubio, John M Kane
Behavioural Brain Research
|
January 8, 2021
Towards a framework to develop neuroimaging biomarkers of relapse in schizophrenia
Jose M Rubio, Anil K Malhotra, John M Kane
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)
|
June 2, 2018
What is the risk-benefit ratio of long-term antipsychotic treatment in people with schizophrenia?
Christoph U Correll, Jose M Rubio, John M Kane
CNS Drugs
|
June 1, 2023
Early Non-Response to Antipsychotic Treatment in Schizophrenia: A Systematic Review and Meta-Analysis of Evidence-Based Management Options
Jose M Rubio, Daniel Guinart, John M Kane, et al.
Schizophrenia Bulletin
|
August 6, 2021
Predictors of Lack of Relapse After Random Discontinuation of Oral and Long-acting Injectable Antipsychotics in Clinically Stabilized Patients with Schizophrenia: A Re-analysis of Individual Participant Data
Georgios Schoretsanitis, John M Kane, Christoph U Correll, et al.
Schizophrenia Research
|
April 3, 2012
Examining the course of hallucinatory experiences in children and adolescents: a systematic review
Jose M Rubio, Julio Sanjuán, Ludwing Flórez-Salamanca, et al.
Psychiatric Services (Washington, D.C.)
|
November 10, 2020
Using Claims Data to Assess Treatment Quality of First-Episode Psychosis
Christopher Reist, Elise Valdes, Yingqian Ren, et al.
Page
of 8